US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2576 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores

Newly added tissue microarrays in recent month:

2017-02-14 BRC51, Breast cancer tissue array with normal breast tissue as control, including TNM, clinical stage and pathology grade, 5 cases/5 cores, Her-2 IHC marker
2017-02-13 SO751a, Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM, 39 cases/72 cores, replacing SO751
2017-02-13 OV803c, Ovary cancer tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing OV803b
2017-02-13 FDA903a-1, Frozen multiple organ normal tissue array, 45 cases/45 cores, replacing FDA903-1
2017-02-13 FDA903a-2, Frozen multiple organ normal tissue array, 45 cases/45 cores, replacing FDA903-2
2017-02-07 T089b, Breast cancer tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T089c
2017-02-07 T089c, Breast cancer tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T089b
2017-02-01 ME1004f, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replacing ME1004e
2017-01-25 CO20814a, Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases/208 cores replacing CO20814
2017-01-24 T301a, Heart tumor tissue array, with normal heart tissue, including TNM, 6 cases/24 cores, replacing T301
2017-01-22 LC2165, Non-small cell lung cancer tissue array (all samples are from 2006 to 2012), including TNM and pathology grade, 108 cases/216 cores
2017-01-22 PA501, Pancreas cancer tissue array, including TNM and pathology grade, 50 cases/50 cores
2017-01-22 LC817a, Lung cancer with matched lymph node metastasis tissue array, including TNM and pathology grade, 40 cases/80 cores, replacing LC817
2017-01-22 BR501, Breast cancer tissue array, including TNM and pathology grade, 50 cases/ 50 cores
2017-01-22 MY801, Mesentery primarily malignant tumor tissue array, 40 cases/80 cores
2017-01-22 LC2164, Non-small cell lung cancer tissue array (all samples are from 2006 to 2012), including TNM and pathology grade, 108 cases/216 cores
2017-01-20 LC2163, Non-small cell lung cancer tissue array (all samples are from 2006 to 2012), including TNM and pathology grade, 108 cases/216 cores
2017-01-16 OV241c, Ovary cancer with adjacent normal ovary tissue array, including TNM and pathology grade, 12 cases/24 cores, replacing OV241b
2017-01-16 BC05002b, Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases/80 cores,replacing BC05002a
2017-01-16 BS17016b, Brain glioblastoma tissue array, including pathology grade, 40 cases/80 cores, replacing BS17016a